Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
460-02-002 ISMRM Abstract

Predicting 3-years Alzheimer’s Disease progression using deep-learning based quantification of brain volumetry

Accepted
Lina Bacha 1,2,3, Bénédicte Maréchal1,2,3, Punith Bidarakka Venkategowda4,5, Keerthi Prabhu M4, Jean-Philippe Thiran3, Jonathan A Disselhorst1,2,3, Alessandra Griffa6, Gilles Allali6, Tommaso Di Noto1,2,3
1Swiss Innovation Hub, Siemens Healthineers International AG, Lausanne, Switzerland
2Department of Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
3LTS5, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
4Magnetic Resonance, Siemens Healthineers India, Bangalore, India
5International Institute of Information Technology Bangalore, Bangalore, India
6Leenards Memory Center, Department of Clinical Neurosciences, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland
Presenting Author: Lina Bacha

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. World Health Organization. (2025, March 31). Dementia. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/dementia
2. Zhu, Y., Cheng, S., Luo, Z., Shen, J., Cao, J., Yao, L., Zhou, J., Shan, S., Song, P., & Yuan, C. (2025). Global burden, quality of care, and cross-country inequalities in alzheimer’s disease and other Dementias from 1990 to 2021. Journal of Global Health, 15. https://doi.org/10.7189/jogh.15.04269 [doi]
3. Rasmussen, J., & Langerman, H. (2019). Alzheimer’s Disease – Why We Need Early Diagnosis. Degenerative Neurological and Neuromuscular Disease, Volume 9, 123–130. https://doi.org/10.2147/dnnd.s228939 [doi]
4. Bollack A, Pemberton HG, Collij LE, Markiewicz P, Cash DM, Farrar G, Barkhof F; on behalf on the AMYPAD consortium. Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification. Alzheimers Dement. 2023 Nov;19(11):5232-5252. doi: 10.1002/alz.13158. Epub 2023 Jun 12. PMID: 37303269. [doi] [pmid]
5. Haji, B., Zhang, Q., & Tahami Monfared, A. A. (2025). Bridging the gap: A conversion framework for CDR-SB and MOCA scores in alzheimer’s disease and related dementia. The Journal of Prevention of Alzheimer’s Disease, 12(8), 100226. https://doi.org/10.1016/j.tjpad.2025.100226 [doi]
6. Wittenberg, R., Knapp, M., Karagiannidou, M., Dickson, J., & Schott, J. M. (2019). Economic impacts of introducing diagnostics for mild cognitive impairment alzheimer’s disease patients. Alzheimer’s & Dementia: Translational Research and Clinical Interventions, 5(1), 382–387. https://doi.org/10.1016/j.trci.2019.06.001 [doi]
7. Torso, M., Khosropanah, P., Chance, S. A., & Ridgway, G. R. (2025). Predicting progression from MCI to dementia using cortical disarray measurement from diffusion MRI. Alzheimer’s and Dementia, 21(5). https://doi.org/10.1002/alz.70310 [doi]
8. Mofrad, S.A., Lundervold, A.J., Vik, A. et al. Cognitive and MRI trajectories for prediction of Alzheimer’s disease. Sci Rep 11, 2122 (2021). https://doi.org/10.1038/s41598-020-78095-7 [doi]
9. Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999). Prediction of ad with MRI-based hippocampal volume in mild cognitive impairment. Neurology, 52(7), 1397–1397. https://doi.org/10.1212/wnl.52.7.1397 [doi]
10. Nesteruk, M., Nesteruk, T., Styczyńska, M., Barczak, A., Mandecka, M., Walecki, J., & Barcikowska-Kotowicz, M. (2015). Predicting the conversion of mild cognitive impairment to alzheimer’s disease based on the volumetric measurements of the selected brain structures in Magnetic Resonance Imaging. Neurologia i Neurochirurgia Polska, 49(6), 349–353. https://doi.org/10.1016/j.pjnns.2015.09.003 [doi]
11. Petersen, R. C., Aisen, P. S., Beckett, L. A., Donohue, M. C., Gamst, A. C., Harvey, D. J., Jack, C. R., Jagust, W. J., Shaw, L. M., Toga, A. W., Trojanowski, J. Q., & Weiner, M. W. (2010). Alzheimer’s disease neuroimaging initiative (ADNI). Neurology, 74(3), 201–209. https://doi.org/10.1212/wnl.0b013e3181cb3e25 [doi]
12. Venkategowda et al. “Establishing Brain Reference Ranges in Indian Population: Comparison with Westerners and Validation for Parkinsonism Differential Diagnosis”. Submitted in parallel to the Annual Meeting of ISMRM 2025.
13. Ardekani, B. A., Bermudez, E., Mubeen, A. M., & Bachman, A. H. (2016). Prediction of incipient alzheimer’s disease dementia in patients with mild cognitive impairment. Journal of Alzheimer’s Disease, 55(1), 269–281. https://doi.org/10.3233/jad-160594 [doi]
14. Guyon, I., Weston, J., Barnhill, S., & Vapnik, V. (2002). Gene selection for cancer classification using support Vector Machines. Machine Learning, 46(1–3), 389–422. https://doi.org/10.1023/a:1012487302797 [doi]
15. Fabian, Pedregosa. "Scikit-learn: Machine learning in Python." Journal of machine learning research 12 (2011): 2825
16. Breiman, L. (2001). Random forests. Machine Learning, 45(1), 5–32. https://doi.org/10.1023/a:1010933404324 [doi]
17. Di Noto, T., von Spiczak, J., Mannil, M., Gantert, E., Soda, P., Manka, R., & Alkadhi, H. (2019). Radiomics for distinguishing myocardial infarction from myocarditis at late gadolinium enhancement at MRI: Comparison with subjective visual analysis. Radiology: Cardiothoracic Imaging, 1(5). https://doi.org/10.1148/ryct.2019180026 [doi]
18. Jacobs, H. I. L., Van Boxtel, M. P. J., Jolles, J., Verhey, F. R. J., & Uylings, H. B. M. (2012). Parietal cortex matters in alzheimer’s disease: An overview of structural, functional and metabolic findings. Neuroscience & Biobehavioral Reviews, 36(1), 297–309. https://doi.org/10.1016/j.neubiorev.2011.06.009 [doi]
19. Alzheimer’s Society. (2019). Dementia and the brain Factsheet 456LP. Alzheimer’s Society. Retrieved from https://www.alzheimers.org.uk/.

Cite this abstract